These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Evans DM, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV. Nature; ; 314(6011):548-50. PubMed ID: 2986004 [Abstract] [Full Text] [Related]
28. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Svitkin YV, Cammack N, Minor PD, Almond JW. Virology; 1990 Mar 25; 175(1):103-9. PubMed ID: 2155504 [Abstract] [Full Text] [Related]
29. Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus. Weeks-Levy C, Tatem JM, DiMichele SJ, Waterfield W, Georgiu AF, Mento SJ. Virology; 1991 Dec 25; 185(2):934-7. PubMed ID: 1660210 [Abstract] [Full Text] [Related]
30. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. Mattion NM, Reilly PA, DiMichele SJ, Crowley JC, Weeks-Levy C. J Virol; 1994 Jun 25; 68(6):3925-33. PubMed ID: 8189529 [Abstract] [Full Text] [Related]
31. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, Cano FR, Mento SJ. J Virol; 1992 May 25; 66(5):3194-7. PubMed ID: 1313923 [Abstract] [Full Text] [Related]
32. Towards development of an in vitro translation test for poliovirus neurovirulence. Svitkin YV, Alpatova GA, Lipskaya GA, Maslova SV, Agol VI, Kew O, Meerovitch K, Sonenberg N. Dev Biol Stand; 1993 May 25; 78():27-32. PubMed ID: 8388829 [Abstract] [Full Text] [Related]
33. Strategy for construction of live picornavirus vaccines. Nomoto A, Iizuka N, Kohara M, Arita M. Vaccine; 1988 Apr 25; 6(2):134-7. PubMed ID: 2838985 [Abstract] [Full Text] [Related]
34. Genetic analysis of the attenuation phenotype of poliovirus type 1. Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler BL, Kameda A, Itoh H, Arita M, Wimmer E. J Virol; 1986 May 25; 58(2):348-58. PubMed ID: 3009852 [Abstract] [Full Text] [Related]
35. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3. Rezapkin GV, Douthitt M, Dragunsky E, Chumakov KM. Virus Res; 1999 Dec 15; 65(2):111-9. PubMed ID: 10581384 [Abstract] [Full Text] [Related]
38. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain). Ubertini TR, Cioni C, Perini L, Gagnoni S. Vaccine; 1988 Dec 15; 6(6):481-2. PubMed ID: 2854337 [Abstract] [Full Text] [Related]
39. Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2. Pevear DC, Oh CK, Cunningham LL, Calenoff M, Jubelt B. J Gen Virol; 1990 Jan 15; 71 ( Pt 1)():43-52. PubMed ID: 2154539 [Abstract] [Full Text] [Related]
40. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Pliaka V, Kyriakopoulou Z, Tsakogiannis D, Ruether IG, Gartzonika C, Levidiotou-Stefanou S, Krikelis A, Markoulatos P. Eur J Clin Microbiol Infect Dis; 2010 Dec 15; 29(12):1513-23. PubMed ID: 20820837 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]